A branching DOS strategy for an unbiased natural product-like library with embedded privileged benzopyran motif was established to provide complexity and diversity of resulting heterocycles with desired drug-likeness. The importance of skeletal diversity conducted on a privileged substructure was demonstrated through the biological evaluation of a small molecule library representing 22 unique core skeletons via in vitro cytotoxicity assay.
建立了一种分枝的
DOS策略,用于制备无偏倚的、类似
天然产物库的分子库,其中嵌入特权苯并
吡喃结构基元,以提供具有期望的类药性的
杂环化合物的复杂性和多样性。通过体外细胞毒性检测,对代表22种独特核心骨架的小分子库进行
生物活性评估,展示了以特权子结构为基础的骨架多样性的重要性。